ERBB2 and aneurysmal bone cyst: Several RCTs have investigated the efficacy of sorafenib in combination with systemic therapies for the treatment of HER2-negative ABC (by fluorescence in situ hybridization or immunohistochemistry), however, the results have been inconsistent.